Achieved 100% ORR and 83.3% CR rate at dose level 2 following a single infusion in patients with relapsed/refractory B-NHL…
RIYADH, Saudi Arabia, June 14, 2026 (GLOBE NEWSWIRE) -- At HLTH Europe 2026 in Amsterdam, taking place from June 15…
June 13, 2026 16:00 ET | Source: Ascendis Pharma Multi-organ system and quality-of-life benefits sustained through three and a half…
New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's health supplement market has entered a new era…
BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong Embodied AI Challenge (the “HOPE AI Challenge”) —…
MONACO, June 12, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after the project unveiled AlphaSwap Early…
MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a global provider of IT solutions…
-- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat…
June 13, 2026 07:30 ET | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3 clinical trial presented today in…
TALVEY® plus daratumumab with or without pomalidomide showed progression-free survival of up to 81.3% and overall survival of up to 89.2% at 24…